SRVEX
Price
$26.51
Change
-$0.23 (-0.86%)
Updated
Jul 13 closing price
Net Assets
397.64M
VFFSX
Price
$367.80
Change
-$2.94 (-0.79%)
Updated
Jul 13 closing price
Net Assets
1.67T
Interact to see
Advertisement

SRVEX vs VFFSX

SRVEX vs VFFSX Comparison Chart in %
View a ticker or compare two or three
VS
SRVEX vs. VFFSX commentary
Jul 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SRVEX is a Buy and VFFSX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VFFSX has more cash in the bank: 1.67T vs. SRVEX (398M). VFFSX pays higher dividends than SRVEX: VFFSX (1.08) vs SRVEX (0.21). SRVEX was incepted earlier than VFFSX: SRVEX (37 years) vs VFFSX (10 years). SRVEX (1.05) is less costly to investors than VFFSX (0.01). SRVEX is a more actively managed with annual turnover of: 92.00 vs. VFFSX (2.00). SRVEX has a lower initial minimum investment than VFFSX: SRVEX (2500) vs VFFSX (5000000000). VFFSX annual gain was more profitable for investors over the last year : 21.07 vs. SRVEX (13.10). VFFSX return over 5 years is better than : 73.48 vs. SRVEX (18.56).
SRVEXVFFSXSRVEX / VFFSX
Total Expense Ratio1.050.0110,500%
Annual Report Gross Expense Ratio1.050.0110,500%
Fund Existence37 years10 years-
Gain YTD11.04710.685103%
Front Load6%N/A-
Min. Initial Investment250050000000000%
Min. Initial Investment IRAN/AN/A-
Net Assets398M1.67T0%
Annual Yield % from dividends0.211.0819%
Returns for 1 year13.1021.0762%
Returns for 3 years33.6468.4549%
Returns for 5 years18.5673.4825%
Returns for 10 years47.00251.2119%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LZIEX20.58N/A
N/A
Lazard International Equity Instl
CMNWX91.13N/A
N/A
Principal Capital Appreciation A
PRWCX38.43N/A
N/A
T. Rowe Price Capital Appreciation
TRZYX24.28N/A
N/A
T. Rowe Price Latin America Z
MCYSX16.25-0.50
-2.99%
NYLI Candriam Emerging Markets Eq Cl R6